
New treatment guidelines, a genetic first in cats, and fresh options in anesthesia make up the first half of our countdown of the year’s most-read stories.
Dr. David Bruyette comments on the latest developments in treating canine PDH and whether or not pituitary surgery will take the place of medical therapy.
David S. Bruyette, DVM, DACVIM, comments on the latest developments in treating pituitary-dependent hyperadrenocorticism in dogs and whether or not pituitary surgery will take the place of medical therapy.
